← Back to Clinical Trials
Recruiting NCT06546813

NCT06546813 Outcomes of ICT Assistive Technology in RehabiliTAtIoN Pathways

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06546813
Status Recruiting
Phase
Sponsor Fondazione Don Carlo Gnocchi Onlus
Condition Communication Aids for Disabled
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2023-06-01
Primary Completion 2025-09-30

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
scales and questionnaire administration

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2023-06-01 with a primary completion date of 2025-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims to improve the quality of prosthetic intervention and verify the adequacy of assistive devices, and measurement outcomes. Fifty patients in need of prosthetic interventions for Augmentative Alternative Communication, computer accessibility, and environmental control will be recruited within the DAT Unit of the Fondazione Don Carlo Gnocchi "IRCCS S.Maria Nascente" in Milan. At baseline (T0) a physician and a psychologist will perform a clinical evaluation and the AT outcome assessment. The participants will be contacted for the follow-up phase (T1) 3 to 6 months after having received the assistive solution. At T1 clinicians will readminister the AT outcome assessment. In order to make the assessment accessible to all participants, these tests and questionnaires will be administered on Windows PCs, using Grid3 software, or on a specifically created accessible web page.

Eligibility Criteria

consecutive enrollment of subjects falling within Inclusion Criteria: * patients in need of prosthetic interventions for Augmentative Alternative Communication, computer accessibility, and environmental control * patients who agree to participate in the study Exclusion Criteria: * none

Contact & Investigator

Central Contact

Claudia Salatino

✉ csalatino@dongnocchi.it

📞 +39-0240308283

Principal Investigator

Claudia Salatino

PRINCIPAL INVESTIGATOR

IRCCS Fondazione Don Carlo Gnocchi ONLUS

Frequently Asked Questions

Who can join the NCT06546813 clinical trial?

This trial is open to participants of all sexes, studying Communication Aids for Disabled. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06546813 currently recruiting?

Yes, NCT06546813 is actively recruiting participants. Contact the research team at csalatino@dongnocchi.it for enrollment information.

Where is the NCT06546813 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT06546813 clinical trial?

NCT06546813 is sponsored by Fondazione Don Carlo Gnocchi Onlus. The principal investigator is Claudia Salatino at IRCCS Fondazione Don Carlo Gnocchi ONLUS. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology